Undefeated—Changing the phenamacril scaffold is not enough to beat resistant Fusarium
Undefeated—Changing the phenamacril scaffold is not enough to beat resistant Fusarium
复制标题
DOI:
10.1371/journal.pone.0235568
复制
发表时间:
2020-06
期刊:
影响因子:
3.7
通讯作者:
R. Wollenberg;S. S. Donau-S.;M. Taft;Z. Balázs;Sven H. Giese;C. Thiel;J. L. Sørensen;T. T. Nielsen-T.;H. Giese;D. Manstein;R. Wimmer;T. E. Sondergaard
中科院分区:
文献类型:
--
作者:
R. Wollenberg;S. S. Donau-S.;M. Taft;Z. Balázs;Sven H. Giese;C. Thiel;J. L. Sørensen;T. T. Nielsen-T.;H. Giese;D. Manstein;R. Wimmer;T. E. Sondergaard
Filamentous fungi belonging to the genus Fusarium are notorious plant-pathogens that infect, damage and contaminate a wide variety of important crops. Phenamacril is the first member of a novel class of single-site acting cyanoacrylate fungicides which has proven highly effective against important members of the genus Fusarium. However, the recent emergence of field-resistant strains exhibiting qualitative resistance poses a major obstacle for the continued use of phenamacril. In this study, we synthesized novel cyanoacrylate compounds based on the phenamacril-scaffold to test their growth-inhibitory potential against wild-type Fusarium and phenamacril-resistant strains. Our findings show that most chemical modifications to the phenamacril-scaffold are associated with almost complete loss of fungicidal activity and in vitro inhibition of myosin motor domain ATPase activity.